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Abstract
Amylin (hIAPP) aggregates have been found in 90% of patients with type II diabetes at
autopsy, and are suspected to play a role in the death of islet β-cells1. However, this aggregation
process is not well understood. Here, we explore methods that utilize capillary electrophoresis
(CE) as a means to better understand amylin’s aggregation process.
We examined the effects of solutions conditions: agitation, pH, salt, and temperature on
amylin aggregation using Thioflavin T, dot blots, and capillary electrophoresis. Thiofalvin T
was used to predict the lag time to β-sheet formation. Our results indicated all variables with the
exception of agitation were feasible for study with CE. Capillary electrophoresis was then
employed to observe the formation of oligomers with dot blots used as a confirmation technique.
Overall, results showed all solutions conditions examined promote aggregation, however there
was variance between time courses. Conflicting results suggest further study is needed to fully
understand the observed amylin aggregation phenomena.
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Chapter 1
Introduction and Background
Amylin and Diabetes
Diabetes mellitus is the seventh leading cause of death in the United States resulting in
the death of over 73,000 people every year 2. It is estimated that over 25 million residents, 8% of
the population, have diabetes and an additional 7 million more are undiagnosed. The number of
people that are predisposed to diabetes is almost 80 million and this number is growing at a rate
of almost 2 million a year. The total healthcare costs for diagnosed diabetic patients is $174
billion dollars 2.
Almost 90% of all cases of diabetes mellitus are considered to be type 2 3. Patients with
type 2 diabetes mellitus are completely insulin dependent. Their bodies do not produce enough
insulin to regulate blood glucose levels. This lack of blood glucose regulation leads to
hyperglycemia resulting in multiple complications including heart disease, blindness, kidney
failure, neuropathy, and amputation. The primary cause of diabetes can result from various
medical conditions including obesity or from a genetic predisposition. However, obesity garners
the most attention, accounting for 55% of type 2 cases 22,1. Between 1995 and 2005 the rate of
diabetes diagnoses doubled prompting the CDC to characterize it as an epidemic 3.
Type 2 diabetes is typically due to an insulin deficiency. Insulin is a regulatory protein
that is produced in the β – cells of the pancreas. It controls glucose uptake into tissue. Over
time, in patients with type 2 diabetes, less and less insulin is produced eventually resulting in no
insulin production. This is due to decreased β - cell function and ultimately β - cell death4. One
possible reason for decreased function and ultimately the death of these β – cells is thought to be
the aggregation process of human islet amyloid polypeptide (hIAPP) as it moves toward the
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formation of an amyloid plaque. At some point during the development of this plaque the
amyloid proteins become toxic to the β – cells 1.
Human Islet Amyloid Polypeptide (hIAPP aka amylin) is a 37 residue protein with a
disulfide bridge between amino acids 2 and 7 as seen in Figure 1 5. It is secreted in the pancreas
by islet β – cells, at the same time as insulin in a ratio of 100 insulin proteins to each amylin
protein 6. Amylin works to reduce the body’s demand on insulin. It slows gastric emptying,
reduces the intake of food, and inhibits gastric secretion7. These actions lead to reduced glucagon
production which in turn slows the rate of glucose appearance8. Physiological concentrations of
amylin are very small (4 – 25 pmol/L) 1.
KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY (Disulfide bridge: 2-7)
Figure 1: Amylin amino acid sequence
In patients with type 2 diabetes, amylin has a propensity to aggregate forming amyloid
plaques. These amyloid plaques are found in more than 90% of patients with type 2 diabetes at
autopsy 1. There is a growing trend of thought that believes this aggregation process is harmful
to pancreatic β – cells, but the knowledge of this potentially toxic mechanism is not well
understood9. Recent in vitro studies have shown that amylin aggregates are toxic to both human
and modified rodent β – cells 10.
Unfortunately, these interactions between amylin and β – cells are not easily identifiable.
The general trend of thought is that the aggregates somehow damage the membrane of the β –
cells11. Further confusion is added when the aggregation mechanism is broken down into
subsequent parts. Initially amylin begins as a monomer and then progresses to an oligomeric
state, next is a transition state known as a proto-fibril state, followed by a fibril state resulting in
the formation of an amyloid plaque. Initially it was thought that the amyloid plaques formed
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from fibrils were the cause of β – cell death. However, recent research has indicated this is not
the case, instead suggesting that smaller amylin aggregates are more important than large
aggregates 12. The current prevailing view now points toward oligomers and/ or the proto – fibril
state as the leading factors for β – cell membrane damage. This coincides with the structural
transition of the protein from an α – helix to a β – sheet13.
The specific mechanism(s) by which amylin destroys β – cells remains unclear.
However, there have been several proposed. One possible mechanism is that amyloid plaques
impair the flow of glucose to β – cells and the flow of insulin from β – cells 10. Another possible
mechanism is that oligomers or proto-fibrils form small pores in the β – cell membrane. These
pores allow various ions into the cell which results in cellular apoptosis 14. A third mechanism is
aggregation due to poor dietary choices. Western diets have been characterized by an increased
intake of dietary fat resulting in an increase of free fatty acids in the body. Studies have shown
that excess fat impairs β-cell function, decreases insulin production, and can stimulate IAPP
aggregation. None of the studies were able to determine the mechanism of amylin aggregation 4,
15

.

Thioflavin T
ThioflavinT (ThT) is a florescent dye commonly used to observe the formation of protofibrils and fibrils in amyloid proteins. The formation of fibrils involves a structural change
moving from α-helix to β-sheet 16. When ThT is added to a sample of an amyloid protein
containing cross β-sheet structures it forms a complex with the fibrils and fluoresces. While by
itself ThT exhibits weak excitation and emission wavelengths at 350 and 440 nm 17, when bound
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to β-sheet structures the dye has excitation and emission wavelengths at 440 and 490 nm 17, 18.
The method of ThT interaction with amloid proteins is not well understood, however the
prominent theory indicates ThT intercalates between grooves of the side chains of the amyloid
fibrils. ThT binding within these grooves stiffens the fibril and prevents it from twisting into a
less radiative state 17. ThT binding has been previously used to identify effects of solution
conditions on β-sheet formation in amyloid proteins 19, 20. While studying the effects of
rifampicin on β-sheet formation researchers were able to monitor β-sheet formation using ThT
. In a separate study, researchers were able to successfully utilize ThT to monitor β-sheet
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formation while researching the toxicity of β-sheets in amylin. They found that the cytotoxicity
of amylin is dependent upon its preparation and the amount of fibrils within the sample 20.
This is a common technique used to monitor β-sheet formation in amyloid proteins. For
the current studies, we have used ThT binding to evaluate the effect of solution conditions on the
lag time to formation of beta sheets during amylin aggregation and to establish a time-line for
fibril formation.

Capillary Electrophoresis
Capillary electrophoresis (CE) is a separation and analysis technique used to differentiate
ionic species based upon their charge and size. CE utilizes a voltage to induce a current to pull a
species through the capillary. Species with a larger charge will travel more quickly than those
with a smaller charge, and species with a larger mass will travel more slowly than those with a
smaller mass
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Previous work by Pryor et. al. has indicated the potential for CE to detect and monitor
amyloid aggregation in amyloid β and insulin proteins 21, 22. Amylin aggregation has been
studies via thioflavin T, dot blots, electron microscopy, light scattering, and several other
techniques, but has yet to be examined using CE 23-25. Capillary electrophoresis could provide a
better, more affordable alternative for the detection and monitoring of amylin oligomer
development and aggregation.

Dot Blots
Dot blots refer to a common technique used for the detection and identification of
proteins 10, 19. Dot blots utilize antibodies to detect the presence of and/or confirm the specific
state of a protein. The dot blot assay involves the attachment, or spotting, of a protein onto a
membrane followed by the binding of a primary antibody specific for that protein. A secondary
antibody then binds to the primary for detection 10. Dot blots give no specific information about
species size. They can only confirm the presence of a specific species22. Previous research
indicates that dot blots can be used to study amylin oligomer formation and aggregation. In a
study by Zhao et. al .researchers were successfully able to utilize dot blots to detect the presence
of amylin oligomers within the pancreatic islet cells of diabetic patients 25. In a separate study
conducted by Meier et. al. to monitor the toxicity of fibrils towards β-cells, dot blots were
successfully used to detect the presence of amylin oligomers 19.

In this work, dot bots were

used to confirm the presence of oligomers and fibrils in conjunction with capillary
electrophoresis.
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Purpose of This Work
Previous research in our lab has indicated that amyloid protein aggregation can be
affected by various solutions conditions. Here, we have examined the effects of these solutions
conditions on amylin aggregation using Th-T, CE, and Dot Blots. Chapter 2 summarizes a study
that used ThT to identify the time at which β-sheet formation occurred for each solution
condition. In Chapter 3, we described the use of CE as to examine oligomer formation and
confirmation of the analysis through dot blots.
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Chapter 2
Beta Sheet detection using ThT
Introduction
Benzothiazole dye thioflavin T (ThT) fluorescence is a well-known, commonly used
technique for the identification of β-sheets in amyloid proteins 17, 23, 26. When amyloid proteins
transition from an oligomer state to a fibril state there is a shift to a β-sheet formation 16. When
ThT is added to solutions containing β-sheet rich structures it experiences a shift in fluorescence
excitation (350 to 440 nm) and emission (438 to 490 nm) maxima 17. It is thought that ThT
intercalates within the grooves formed by amino acid side chains of the amyloid fibril17l. ThT
does not bind to monomers or oligomers, it only binds to β-sheet rich structures 26. ThT has been
previously used to identify the effects of solution conditions on β-sheet formation in amyloid
proteins 19, 20.
A ThT assay involves the dilution of fibril forming amyloid samples into buffered ThT
followed by taking a fluorescence reading 20. Fluorescence time courses generally have the
shape of a sigmoidal curve. In the beginning there is a lag phase followed by an increase after
which there is a leveling off. The beginning of the sharp increase is indicative of β-sheet
formation and the leveling or tapering off indicates fibril/ β-sheet saturation. In this chapter we
used ThT to both monitor and to determine the threshold of β-sheet formation for amylin within
our sample solutions conditions. We examined the effects of both increased and decreased
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agitation, increased pH, salt, and temperature, as well as a combination of these variables. These
are controllable conditions that are known to affect amylin aggregation speed.

Materials and Methods
Amylin Preparation
Amylin (Anaspec, Freemont CA, Lot #88089), was stored at -80oC. To ensure samples
were monomeric a 3.91 mg/ml stock of amylin was prepared in Hexofluoro-2-propanol (HFIP)
27

. Amylin was aliquotted into vials containing 0.0625 mg of amylin and the HFIP was allowed

to evaporate overnight. For ThT studies, amylin was prepared to a concentration of 50 µM under
the various conditions specified in Table 1. All samples were examined in triplicate. Tris buffer
was chosen based upon previous work in our lab with amyloid – β. Other buffers, such as
phosphate buffer, could provide more physiological conditions, however tris provides a more
stable environment for separation within CE.
Table 1: Solutions conditions. Changes from the Control are highlighted in red.
Sample

pH

T (C)

Agitation (rpm)

NaCl (mM)

Control

8

25

400

5

pH

7

25

400

5

Salt

8

25

400

140

Agitation1

8

25

0

5

Agitation2

8

25

800

5

Temperature

8

37

400

5

Multiple Variables

8

37

0

140
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Fluorescence Measurement
To measure fluorescence we used a Shimadzu RF-Mini-150 Fluoremeter (Columbia,
MD) (excitation filter = 460 nm, emission filter = 490 nm). ThT solution was initially prepared
to a 1 M concentration with Milli Q water and then diluted to a 5:1 concentration ratio of 35.73
µM ThT and 50 µM amylin using tris – HCl. Volume ratio was 7:1 (175 µL ThT to 25 µL_
Amylin. Time points’ fluorescence readings were taken a minimum of 2 hours and a maximum
of 6 hours apart. As part of the purpose of this study was to establish conditions that would be
suitable for future CE analysis, only aggregation occurring at times greater than 2 hours or less
than 24 hours were evaluated. Based on previous work with amyloid β and capillary
electrophoresis, β-sheet formation occurring in less than 2 hours does not allow enough time for
a time course study. β-sheet formation after 24 hours was considered undesirable for being able
to effectively capture all in between time points.

Statistical Analysis
Results were analyzed with an unpaired t test using GraphPad QuickCalcs
(http://www.graphpad.com/quickcalcs/ttest1.cfm). We inputted the mean, standard deviation,
and sample size to calculate each time point’s p value in relation to the zero hour time point. The
first time point statistically significant in comparison to the zero hour time point was deemed to
represent β-sheet formation. Time points were considered to be statistically significant when
their p value became less than 0.05.

9

Results and Discussion
The effect of solution conditions on lag time to β-sheet formation was investigated. βsheet formation was determined to have taken place when a time point was deemed to be
statistically different from the zero hour time point. A confidence interval of 95% was used to
determine when a time point was significant in comparison to the zero time point.

Control Conditions
The control conditions were selected based upon previous work performed with another
amyloid forming protein, amyloid-β 28. While there are other more physiological conditions
available; these conditions have been found to work best with our chosen buffer, tris. As shown
in Figure 2, time points were taken at 0, 6, and 10 hours followed by a time point every 2 hours
up to 20 hours. In comparison to the zero hour time point at 6 hours fluorescence readings had
hardly increased, but at 12 hours fluorescence had increased by 67%. This was followed by a
general leveling off with fluorescence where readings remaining generally around 500 for the
next 10 hours. Based on a t test with a 95% confidence interval it was found that the control
conditions exhibited a significant difference in fluorescence at 12 hours which indicated this to
be the lag time to β – sheet formation.
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Figure 2: Change in fluorescence indicating β – sheet formation in amylin samples under
Control conditions. The red square indicates the first statistically significant point.

Study of Agitation
In this study we chose to examine the effects of agitation by evaluating no agitation (0
rpm), medium agitation (400 rpm), and high agitation (800 rpm). Time points for 0 rpm were
taken at 0, 6, 12, 16, 18, 20, 22, and 24 hours. Time points for 800 rpm were taken every 2 hours
for 12 hours. Time points for each agitation sample set were different because we expected
higher agitation would increase the rate of aggregation and decrease the sample lag time
requiring us to measure fluorescence sooner.
Figure 3 shows the results of the ThT study for the varying aggregation conditions. The
0 rpm agitation study did not show statistically significant β-sheet production until the final 24
hour time point. The 800 rpm agitation study produced its first statistically significant time point
at 2 hours. An interesting occurrence to note is the amount of fluorescence detected in the 800
rpm agitation study. The first significant time point had a fluorescence reading of 218. This was
followed 2 hours later by a fluorescence reading of 2000, an increase of 89%. The fluorescence
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stayed around 2000 for the next 6 hours. In comparison to our other ThT studies, this is a much
greater amount of fluorescence. The maximum fluorescence detected in the control study was
500, and the maximum fluorescence detected in our other studies never exceeded 1500. ThT
binds to β – sheets so therefore the 800 rpm agitation assay resulted in a much higher
concentration of β – sheets. In comparison to the control conditions, which exhibited significant
β-sheet formation at 12 hours, it is reasonable to say that a lack of agitation can slow the in-vitro
aggregation time of amylin. In respect to the 800 rpm study it can be said that an increase in
agitation can increase the in-vitro aggregation time of amylin. This is consistent with the results
of a recent study by Tiiman et al. who observed that an increase in agitation of another amyloid
forming protein, amyloid β, resulted in a dramatic increase in fluorescence in comparison to
those without agitation 29. Therefore agitation sample concentrations one could draw the
conclusion that increased agitation or lack thereof can have a profound impact on the aggregation
of amyloid proteins in vitro.
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Figure 3: Change in fluorescence indicating β – sheet formation in amylin samples with 0 rpm
agitation and 800 rpm agitation in comparison to Control conditions 400 rpm. The red square
indicates the first statistically different point.

Study of pH
The pH study was selected to investigate the effects of a more acidic pH in comparison to
the control pH of 8. We initially planned to observe the effects of a more basic and a more
acidic pH on amylin aggregation. However, we were limited due to the range of our chosen
buffer, pH 7.1 – pH 9, and by the isoelectric point of amylin which is at a pH of 8.9. When a
protein is at or near its isoelectric point it will most likely aggregate 30. Performing our study at a
pH higher than the control’s pH of 8 would have been too close to amylin’s isoelectric point. It
was therefore decided to investigate the effects of more acidic conditions on amylin aggregation.
Our pH study was conducted at a pH of 7.1. Time points were taken every 2 hours for 8 hours,
and then every 4 hours until 24 hours was reached. Fluorescence results can be seen in Figure 4.
The pH condition had a lag time to significant β-sheet formation of 4 hours. In comparison to the
control conditions our pH study did form β-sheets more quickly as evidenced by the faster
13

increase in fluorescence. This time point compares similarly to the increased agitation assay
though it is different. The largest fluorescence reading is just over 500. However when graphed,
the time points, instead of forming a typical sigmoidal curve, formed more of a parabolic shape.
It would be expected for the fluorescence to increase and then level off, however, after 12 hours
there was a decrease in fluorescence. This could be due to a rapid increase in β – sheet
formation followed by the fibrils falling out of solution.
Our study suggests that a decrease in pH will result in a decrease in aggregation time.
This is contrary to a previous amylin study which found that amyloidosis achieved a maxima at
pH 9.5 and the rate of fibrillation was similar for the range of pH 6.5 to pH 8.5 24 Their study
varied in that it used a different aggregation procedure, disoving their sample in DMSO, utilizing
higher concentrations of amylin up to 150 µM. They also had increased salt, up to 200 µM, as
well as lower temperature, 4 and 22oC, and a different buffer. The differences in our studies
could be related to these variations.
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Figure 4: Change in fluorescence indicating β – sheet formation in amylin samples under pH
conditions. The red square indicates the first statistically significant point of β-sheet formation.

Study of Salt
The salt conditions were selected to investigate the effects of the addition of a high
concentration of salt in comparison to the control conditions. A concentration of 140 mM was
chosen to satisfy the requirement of a high salt concentration, which was partially selected since
it is comparable to the concentration of salt within the human body 31. Time points were
recorded every 2 hours for 12 hours with a final time point occurring at 24 hours. Time course
results can be seen in Figure 5. The first significant fluorescence occurred at 4 hours. It
achieved a fluorescence of 1000 at 8 hours which it maintained for 12 more hours. Though
taking longer to develop a significant amount of β-sheets than the increased agitation condition,
the increased salt condition developed β-sheets much faster than the control condition. From
this we determined that an increase in salt concentration will result in a decrease in aggregation
time. This is in agreement with a previous study by Jain et al. which monitored the effects of
15

increased salt on amyloid fibril formation. They monitored fluorescence in the presence of 120,
130, and 150 mM NaCl and found that an increase in salt concentration resulted in an increase in
the rate of β-sheet formation. A similar study by Pryor et al. showed a decrease in lag time with
increased salt formation for insulin 21.

Fluorescence

1600
1200
NaCl 140 mM

800

5 mM (Control)
400

β-sheet formation

0
0

4

8

12
Time (hr)

16

20

24

Figure 5: Change in fluorescence indicating β – sheet formation in amylin samples under Salt
conditions.

Study of Temperature
Temperature conditions were selected to investigate the effects of increased temperature
in comparison to the control conditions. For the study of increased temperature it was
determined to raise the temperature to 37oC in comparison to the control’s 25oC. This satisfied
the requirement of an increase in temperature and also replicated the average temperature of the
human body 32. Time points were taken every 2 hours for 12 hours and a final time point was
taken at 24 hours. Figure 6 depicts the fluorescence assay results. The lag time to significant βsheet formation was detected at 6 hours. After 4 hours, fluorescence had increased above 1000
and stayed there for the next 20 hours. This is indicative of β – sheet formation occurring very
16

quickly by the 4 hour time point. This is in agreement with previous work by Kudva et al. which
proposes amyloid aggregation is “directly related to temperature” 24. They examined amylin
aggregation under temperatures of 4, 22, and 37oC respectively and found with each increase in
temperature there was an increase in β-sheet formation. In comparison with the control
condition, our results along with previous research indicate an increase in temperature will result
in an increase in β-sheet formation.
1800
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12
Time (hr)
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20

24

Figure 6: Change in fluorescence indicating β – sheet formation in amylin samples under
Temperature conditions.

Study of Multiple Variables
Since the human body is a complex system, we chose to investigate a condition were
multiple variables (salt, temperature, aggregation) varied from the control conditons and were
more in line with mimicking the human body. We chose to increase the salt concentration to 140
mM, to increase the temperature to 37oC, and decrease agitation to 0 rpm while keeping the pH
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at 8.0. Time points were measured every 2 hours for 12 hours and a final time point was taken at
24 hours. Results for this study can be seen in Figure 7.
The first statistically significant point of fluorescence occurred at 4 hours. Fluorescence
increased to above 1000 after 12 hours and maintained fluorescence above 1000 for the final 12
hours. Our previous studies on the effects of varying salt and temperature indicated increases in
both will decrease the aggregation time for β-sheet formation. This study is consistent with
those previous, although they did not appear to act synergistically. Our results indicate
statistically significant β-sheet formation at 4 hours which is similar to the salt study, but less
than the temperature study.
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Figure 7: Change in fluorescence indicating β – sheet formation in amylin samples under
multiple variables.
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Discussion
In this study we monitored the effect of solution conditions on β-sheet formation in
amylin. After reviewing data collected the following general statements can be made concerning
the effect of agitation, temperature, salt, and pH on amylin fibril formation time. An increase in
agitation will result in a decrease in fibril formation time. An increase in temperature will result
in a decrease in fibril formation time. An increase in salt (NaCl) concentration will result in an
increase in fibril formation time. A decrease in pH will result in a decrease in fibril formation
time. Conditions mimicking the body will result in a decrease in fibril formation time. Using
statistical analysis, for each individual study we found the first time point that statistically
significant from the zero hour time point. We used this statistically significant time point to
indicate the lag time before beat sheet (fibril) formation for each study. All expected initial fibril
formation lag times are summarized in Table 2.

Table 2: Expected lag time of beta sheet/ fibril formation based upon a 95% confidence interval.
Study
Control
Agitation 1
Agitation 2
pH
Salt
Temperature
Multiple Variables

Expected Lag Time (hr), p value < .05
12
24
2
4
4
6
4
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Chapter 3: Capillary Electrophoresis
Introduction
Capillary Electrophoresis (CE)
Capillary electrophoresis (CE) is a separation technique used to separate species based on
their charge and size. It employs the use of an applied voltage to generate a current resulting in
species migration. The speed of migration is based upon the electrophoretic mobility of the
species, which is determined by its mass and charge. Analytes that have a larger charge will
move faster than those with a smaller charge. Analytes with a greater mass will move slower
than those with a lesser mass. In capillary electrophoresis the capillary is filled with a buffer
solution. When an electrical field is applied to the buffer filled capillary it induces a flow of
electrolytes toward the cathode. Depending on the analyte’s charge, this flow acts to either
enhance or impede its mobility within the capillary. This flow is further enhanced with a process
known as electro osmotic flow (EOF). EOF occurs when the charge on the inside of the
capillary creates a more concentrated layer of ions which acts to creaste a bulk flow. To utilize
EOF we left the capillary uncoated. The inside of the siliconized capillary is negatively charged.
As the positive ions in the buffer solution migrate towards the cathode they stick to the
negatively charged capillary walls. Other positively charged ions are pulled towards the
capillary wall but are unable stick, creating a mobile concentrated layer. Because there are now
less negative ions to impede it, this concentrated layer moves more easily toward the cathode and
acts to create a bulk flow of ions enhancing the speed of of species migration 33.
For this study, CE was used to detect and monitor hIAPP (amylin) aggregation under
different solutions conditions, similar to those monitored by ThT in Ch.2. At a pH of 8 amylin
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has a charge of +1 and therefore migrates toward the cathode. Therefore, its mobility is
enhanced by the presence of EOF.

Dot Blots
Dot blots are a traditional method used to detect the formation of oligomers and fibrils in
amyloid forming proteins. Dot blots work by employing antibodies to detect the presence of a
protein or specific conformations of a protein. Both A11 and OC antibodies are commonly used
for the detection of amyloid aggregation conformations 25. The A11 antibody has been correlated
with toxic oligomers in amyloid proteins. The OC antibody recognizes amyloid fibrils.
AB18018 was used as a control to recognize human amylin 1-37. AB18018 is specific for the
full length 37 aa human amylin sequence. We chose to use dolt blots with primary antibodies
AB18018, A11, and OC for the detection of amylin oligomers and fibrils in our CE study.

Materials and Methods
Table 1 depicts the solution conditions we analyzed using CE and dot blots. We varied
pH, salt, and temperature, and then combined high salt, increased temperature, and no agitation
for a multiple variable condition. Our control solution condition was based on previous work
with other amyloid forming proteins, insulin and amyloid β 28.
Table 1 was developed using the solutions conditions used for the ThT study in Chapter
2. Sample conditions, Agitation 1 and Agitation 2 were removed due to their aggregation lag
times (Chapter 2, Table 2). Agitation 1 and Agitation 2 had lag times of 2 hours and 24 hours,
respectively. A lag time of 2 hours does not allow enough time for a study with capillary
electrophoresis and 24 hours is to long for a feasible study.
21

Table 1: Solution conditions to be used in Capillary Electrophoresis.
Sample

pH

T (C)

Agitation (rpm)

NaCl (mM)

Control

8

25

400

5

pH

7

25

400

5

Salt

8

25

400

140

Temperature

8

37

400

5

Multiple Variables

8

37

0

140

Amylin Preparation
Human amylin 1-37 (Anaspec, Freemont CA, Lot #88089), was stored at -80oC. In order
to ensure samples were monomeric a 3.91 mg/mL stock of amylin was prepared in hexofluoro-2proponol (HFIP). Amylin was aliquotted into vials containing 0.0625 mg of amylin and the
HFIP was allowed to evaporate overnight. For CE studies, amylin was prepared to a
concentration of 50 µM. All samples were examined in triplicate. Samples were initially
dissolved in 5 mM NaOH for 10 minutes. Following that tris buffer and salt were added
accordingly to make conditions described in Table 1. Samples were then subjected to
temperature and agitation specified by their solution condition in Table 1.

Dot Blots
Dot blots were performed by spotting 2 µl of 50 µM amylin at each time point onto a
nitrocellulose membrane (Pall, Port Washington NY). Primary antibodies used were AB18018
1:10000 dilution (Abcam, Cambridge MA), A11 1:2000 dilution (Invitrogen, Camarillo CA),
and OC 1:4000 dilution (Millipore, Hayward CA). Secondary antibody used was goat anti rabbit
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alkaline phosphatase (Pierce, Rockford IL). Dot blots were developed using NBT/BCIP
developing solution (Thermo Scientific, Waltham MA).

Capillary Electrophoresis
Capillary Electrophoresis was performed using a Beckman Coulter P/ACE MDQ
Glycoprotein System (Fullerton, CA) (214nm filter). The machine was interfaced with an IBM
computer and Beckman Coulter 32.0 Karat software (V 5.0). Samples were pressure injected at
0.5 psi for 8 seconds and separated at 7 kV for 60 minutes in a glass capillary of length, 31 cm.
The capillary was rinsed with deionized water for 10 minutes at 50 psi and then 100 mM TrisHCl for 2 minutes at 20 psi between each time point. The capillary was changed between each
time course to prevent contamination from protein adherence to the capillary wall.
Data Analyzation
Capillary electrophoresis data was analyzed using Origin 8.6 (Origin Lab, Northampton
Ma) and Microsoft Excel 2010 (Microsoft, Redmond Washington). CE data was imported into
Origin 8.6 and analyzed for peak area and elution time. The data obtained was then exported to
excel where it was graphed vs. time.

Results
Control Conditions
Results from CE were plotted vs. time to develop electropherograms. Electropherograms
allow for determination of when an analyte passes the window of a capillary. They are
characterized by a flat baseline interrupted by a positive peak and then a continuation of the
baseline. The peak is generated as the species migrates past the UV window. The peak’s area
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and elution time can be used in comparison to other CE runs to evaluate aggregation changes to
the species. If the species is larger it will take longer to migrate through the capillary and will
therefore result in an increase in elution time. An increase in the amount of species is typically
related to an increase in peak area. Electropherograms can then be plotted against each other to
show changes in between each CE run to develop a time course.
In capillary electrophoresis a negative peak appears in the presence of a UV transparent
sample or zone 34. Interestingly all five conditions (control, pH, salt, temperature, and multiple
variables) exhibited at least one negative peak in each run. If the peak consistently had the same
elution time and area during every run we could simply call it a system peak 34. However, as the
sample aggregation time increased so did the elution time of the negative peak. Figure 1 depicts
a set of electropherograms forming a time course for the control condition as analyzed by CE.
This negative peak occurred in all five solutions conditions, which indicates an increase in size
of the migrating species affecting this negative peak. Previous research has shown negative
peaks to be associated with zones of varying ionic strength 34. With this in mind, we calculated
the ionic strength for both our separation buffer and our sample solution, Table 2. We found that
there were differences in ionic strength for both buffers. This could have contributed to the
appearance of negative peaks.
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Table 2: Sample Ionic Strengths
Sample

Buffer (M)

Sample (M)

Control

0.058

0.052

pH

0.092

0.066

Salt

0.058

0.212

Temperature

0.058

0.045

Multiple Variables

0.058

0.18

The control condition, Figure 1, exhibited this negative peak in all three time course
repeats. The elution time for the peak did increase as aggregation time increased (Figure 2A).
Time course 3 exhibited 2 negative peaks, 3A and 3B. Both of these peaks consistently eluted
within a short amount of time of each other for the entire time course.
The control condition exhibited an increase in the negative peak’s area for all 3 time
courses (Figure 2B). The peak area increases for time courses 1 and 3A and 3B were similar
until the final time point. The increase in peak area for time course 2 was greater than that of
time courses 1 and 3. The control condition did not develop a positive peak.
While there was variance between individual time courses for a given sample condition,
all sample conditions showed a general increase in negative peak area with an increase in
aggregation time. The variance between each time course could be due to protein sticking within
the capillary. Capillaries were changed between each time course to avoid contamination. With
a new capillary being used for each time course there could have been variation in the amount of
protein sticking in each time course.
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Figure 1: Electropherogram of a Control CE run. Peak of interest is the negative peak occurring
between 0 and 10 minutes.
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Figure 2: A. Negative peak normalized control elution times vs. aggregation time. B. Negative
peak normalized control peak area vs. aggregation time.
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Figure 3: Dot blot of Control condition. The presence of a dot confirms the presence of amylin
(ab18018), an oligomer (A11), or fibril (OC). Positive dot blots have been circled because of
difficulty in obtaining the proper contrast in photographs.

Dot blots confirmed the presence of oligomers at the 2 hour time point. The presence of
oligomers was confirmed for the rest of the time course. The presence of fibrils was detected at
all time points. Dot blot results can be seen in Figure 3. While the dots are visible to the eye,
they can be difficult to visualize in an image and therefore circles have been added to indicate
the presence of a dot. The presence of both fibrils and oligomers at time 0 indicates aggregation
was occurring very quickly within our control sample which could explain why no new peaks
were detected.
Study of pH
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Amylin’s isoelectric point is at pH 8.9. When a protein approaches its isoelectric point it
has a propensity to aggregate 30. With this knowledge we assumed a lower pH than our control
would result in an increase in aggregation time. However, results indicated a lower pH resulted
in lower elution times than the control. At a pH of 7 the charge on amylin should be close to +2.
In the control conditions with a pH of 8 the charge of amylin is +1. At pH 7 the charge on
amylin is twice that of the control condition. With a larger charge we expected it to migrate
more quickly than the control.
The lower pH resulted in an increase in elution time for negative peaks but was variable
between each time course. Figure 5A depicts the negative peak elution times. Time course 1
initially had a decrease in elution time, but finished with a final elution time of 1.3 minutes.
Time course 2 at first had a slow increase in elution time but after a 4 hour elution time of 1.15
minutes it increased sharply to 2.5 minutes for the 6 hour time point.
The pH condition showed an increase in negative peak area, but was inconsistent between
each time course as seen in Figure 5B. Time courses 1 and 2 were consistent until the last time
point of which time course 1 had a peak area of 1.2 and time course 2 a peak area of 2.5. Time
course 3 had a greater initial increase than 1 and 2, and finished with a peak area of 2 for the 6
hour time point. Time courses 2 and 3 both finished the 6 hour time point with greater peak areas
than the control.
As seen in Figure 5C, pH elution times for the positive peak were not consistent. The
elution times at the 2, 4, and 6 hour time points for time course 1 were all less than the initial
elution time. Time course 2 showed an initial decrease for time points 2 and 4 followed by an
increase for the 6 hour time point. The CE was unable to detect a peak after 2 hours for the third
time course.
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The pH conditions exhibited an overall decrease in peak area for all three time courses.
Peak area for time course 1 decreased to 0.8 at 6 hours. Peak area for time course 2 decreased to
0.2 by 6 hours Peak area for time course 3 decreased to 0.8 at 2 hours and then was no longer
detectable. Figure 5D depicts positive peak area for all three time courses.
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Figure 4: Electropherogram of a pH run. Peaks of interest are the initial positive peak which is
followed by the negative drop peak.
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Figure 5: A. Negative peak normalized pH elution times vs. aggregation time. B. Negative
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Figure 6: Dot blot of pH condition. Antibody ab18018 confirmed the presence of amylin. A11
confirmed the presence of oligomers. OC confirmed the presence of fibrils.

For the dot blot assays, ab18018 confirmed the presence of amylin at all the time points
(Figure 6). Oligomers were detected at the 0, 2, and 6 hour time points. Although a positive
oligomeric dot is not present as 4 hours, oligomers should be present and therefore it is most
likely an experimental error. Fibrils were detected at all time points. Our dot blot assay
confirmed the presence of fibrils and oligomers at time zero which indicates the positive peak
represents amyloid oligomers/ fibrils.
Our depicts increases in positive peak elution time and decreases in positive peak area.
However these contradict each other. At a pH of 7 amylin has a predicted charge of +2. The
more charge a protein, the less likely it will aggregate 30. Previous work has shown as pH
decreases so too does amylin’s aggregation rate. Researchers found that the rate of amylin
aggregation had maxima at pH 9.5 and that from 8.5 to 5.5 it decreased. 24. Our research along
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with Kudva et al. indicates a lower pH has more complex effects on aggregation making it less
desirable to use as a study condition due to its inconsistency.

Study of Salt
Salt condition, Table 1, caused an increase in elution times and peak area for all time
courses. The three time courses were fairly consistent until the final 6 hour time point. Figure 7
depicts an electropherogram of the Salt condition. Time courses 1 and 3 displayed negative peak
elution times close to 1.6 minutes. Time course 2 however, resulted in a decrease from the four
hour time point, dropping from 1.3 minutes to 1.1 minutes. A comparison of negative peak
elution times can be seen in Figure 8A.
The salt condition resulted in an initial increase of negative peak area for the three time
courses, but following the 4 hour time point, time courses 2 and 3 decreased as shown in Figure
8B. Time course 1 had a slight increase between the 4 and 6 hour time points. While 2 and 3
followed the same trend, there were no similarities in increases of peak area between the time
courses. At the 6 hour time point time course 2 decreased in peak area to less than 1. This
decrease could be due to the transition from an oliogmeric state to a fibril state. The increase in
peak area indicates the presence of more species which could be amylin aggregating from a
monomer to an oligomeric state.
Positive peak elution times can be seen in Figure 8C. The salt condition resulted in
consistent increases in positive peak elution times for all 3 time courses until the final 6 hour
time point. At 6 hours, time course 2 showed a decrease in elution time. The 6 hour elution
times for time courses 1, 2, and 3 were 1.7, 1.1, and 1.6 minutes. The consistent increases in
elution time are indicative of the development of larger species.
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Figure 8D depicts positive peak areas. Salt conditions showed an increase in positive
peak area for all three time courses. Time course 1 finished with a peak area of 6.3. Time
course 2 finished with a peak area of 3.3. Time course 3 finished with a peak area of 3. While
there is variance in peak area, the overall trend of increasing peak area is similar to that of the
positive peak elution time indicating the development of larger species.
Previous work has shown that increased salt concentration can enhance amyloid
aggregation. A study by Kudva showed an increase from 0 to 100 mM NaCl increased the rate
of amylin aggregation by close to 100% 24. A separate study found that aggregation of amyloid
proteins rises with increased salt concentrations up to 500 mM 35. Both our positive peak elution
time and peak area grew with each time point which indicates the presence of an aggregating
species. Salt induced protein aggregation is believed to be caused by what is known as the
hydrophobic effect 36. This occurs when the addition of salt induces the folding of the nonpolar
regions of a protein, promoting enhanced oliogomer and fibril formation 37.
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Figure 7: Electropherogram of Salt condition. There is a system peak at 2 minutes and then a
negative peak. The negative peak is immediately followed by a positive peak.
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Figure 9: Dot blot of Salt condition. Antibody ab18018 confirmed the presence of Amylin.
A11 confirmed the presence of oligomers. OC confirmed the presence of fibrils.

Dot blots for salt condition can be seen in Figure 9. Antibody ab18018 confirmed the
presence of amylin for all time points. Oligomers were detected at 0, 2, and 6 hours. The
presence of fibrils was detected at all time points. The 4 and 6 hour time points were noticeably
darker for the fibril nitrocellulose membrane. While A11 and OC both confirmed the presence
of oligomers and fibrils the final 6 hour time point for both is more noticeable than the previous
points. Combining this with our positive peak area and elution times increases it is reasonable to
suggest that we are monitoring amylin aggregation. However, while dot blots did confirm the
presence of oligomers and fibrils they did not provide any information about the details of the
aggregating species.
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Study of Temperature
Temperature conditions showed an increase in negative peak elution time for all time
courses which can be seen in the electropherogram in Figure 10. Time courses 1 and 2 results
were similar until the final time point. For the 8 hour time point time course 1 had an elution
time of 1.6 minutes. Time course 2 had an elution time of 1.3 minutes. Both time courses
showed a decrease in elution time from the 6 hour to the 8 hour time point. Time course 3
showed an increase in elution time, however it was not similar to time courses 1 and 2. Time
course 3 had an outlier point at 2 hours and did not show a decrease in elution time from the 6
hour to the 8 hour time points. Its 8 hour time point finished with an elution time similar to time
course 2, 1.4 minutes. The overall increase in elution time indicates the development of an
increasingly larger species migrating through the capillary. The third time course was performed
several weeks after the first two, which might explain some of the variation between them.
Negative peak elution times can be seen in Figure 11A.
Temperature conditions resulted in an increase in negative peak area for all time courses.
Figure 11B depicts negative peak areas. Time courses 1 and 2 showed a decrease in peak area
between the 6 and 8 hour time points. There was variance between all three time courses. Time
course 3 only showed slight increases in peak area for the whole time course. The peak areas at
6 hours for time courses 1, 2, and 3 were 2.2, 1.5, and 1.2. With the drop of the final peak area,
temperature displayed a comparable characteristic with the salt condition. Similarly this could
be to the transition from oligomers to fibrils.
The temperature condition exhibited a positive peak in time courses 1 and 3. Time
course 1 showed an increase in peak elution time until decreasing at the 8 hour time point. Time
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course 3 developed a positive peak at the 6 hour time point; however it showed a decrease in
elution time at the 8 hour time point. Figure 11C depicts positive peak elution times.
Temperature conditions resulted in peak area for time courses 1 and 3 and can be seen in
Figure 11D. Time course 1 increased to a peak area of 3.1 at 6 hours and then decreased to a
peak area 2.8 at 8 hours. Time course 3 developed a peak at 6 hours which increased to a peak
area of 2.4 at 8 hours. Time course 2 did not develop a positive peak. The plot of temperature’s
peak area was similar to its plot of elution time. This decrease could be due to progression from
oligomers to fibrils. Previous work by Kudev et al. found that there was a direct relationship
between temperature and amylin aggregation. They studied amylin aggregation at 4oC, 22oC,
and 37 oC 24. They found that increased temperature resulted in higher rates of amylin
aggregation. The increases of elution time and peak area for time course 1 indicate the
development of larger aggregated species, however it is difficult to draw conclusions based on
one time course. Time course 2 did not develop a positive peak, and the positive peak for time
course 3 developed 6 hours after time course 1.

38

0.05

0.04

Absorbance

0.03

0 Hour
2 Hour

0.02

4 Hour
6 Hour
8 Hour

0.01

0
0
-0.01

5

10

15

20

25

30

Time (min)

Figure 10: Electropherogram of Temperature condition. The area of interest is between 0 and
10 minutes. Initially there is a positive peak which is closely followed by a negative peak.
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Figures 11: A. Negative peak normalized temperature elution times vs. aggregation time. B.
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Figure 12: Dot blot of Temperature condition. Antibody ab18018 confirmed the presence of
amylin. A11 confirmed the presence of oligomers. OC confirmed the presence of fibrils.

Dot blots can be seen in Figure 12. Antibody ab18018 detected the presence of amylin
for all time points. Oligomers were detected at the 2 hour time point and confirmed for the rest
of the time course. Fibrils were detected at all time points. The 6 and 8 hour time points were
noticeably darker for both oligomers and fibrils. The detection of both oligomers and fibrils at
the same time indicates amyloid aggregation has occurred we cannot say capillary
electrophoresis was able to monitor oligomer formation. While based on previous studies as
well as our work with ThT, it is reasonable to suggest that increased in temperature will result in
increased amylin aggregation, we were not able to conclusively monitor amylin oligomer
formation 24.
41

Study of Multiple Variables
A combination of multiple variables (MV) showed an increase in negative peak elution
time for each time course as shown in Figure 13. Figure 14A depicts negative peak elution
times. Time course 1 showed the greatest increase in elution time with a final elution time of 1.9
minutes at 6 hours. Time courses 2 and 3 finished with elution times close to 1.5 minutes. In
comparison to the control conditions, MV conditions behaved fairly similarly, but eluted slightly
faster. By 6 hours the elution time was roughly 1.6 minutes while for the control it eluted around
1.3 minutes. The increase could indicate larger aggregated species which could have resulted
from the increased salt concentration as well as the increased temperature which.
Negative peak area can be seen in Figure 14B. The MV condition showed an increase in
negative peak area for each time course, however there was variance between the time courses
for all time points. In comparison with the control at the 6 hour time point the MV condition
finished the time course with slightly greater negative peak areas. With its increase in salt and
temperature it was expected that the body conditions would have greater peak area than the
control yet the control had larger peak areas at the end of its time course.
Figure 14C depicts positive peak elution times. The MV condition showed an increase in
positive peak elution time for all time courses. Time course 1 showed much higher increases in
elution time than time courses 2 and 3. Time courses 2 and 3 showed similar increases until the
6 hour time point with 2 showing an elution time of 1.2 minutes and 3 an elution time of 1.6
minutes. The 6 hour elution times for time course 1 was 2 minutes. While there was variance
between the 3 time courses all showed a general trend of increasing elution time which suggested
the development of larger aggregated species.
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The development of larger aggregates was further confirmed after observing the results of
positive peak area. Positive peak areas can be seen in Figure 14D. MV conditions showed an
increase in positive peak area for all three time courses. The increase for time course 2 was
much less than time courses 1 and 3 with a final peak area of 1.3 at 6 hours. The peak areas for 2
and 3 were about 3 at 6 hours.
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Figure 13: Electropherogram of MV condition. There is a system peak at 2 minutes followed by
a negative peak at 7 minutes which is immediately followed by a positive peak.
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Figures 14: A. Negative peak normalized MV elution times vs. aggregation time. B. Negative
peak normalized MV peak area vs. aggregation time. C. Positive peak normalized MV elution
time vs. aggregation time. D. Positive peak normalized MV peak area vs. aggregation time.
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Figure 15: Dot blot of Body condition. Antibody ab18018 confirmed the presence of amylin.
A11 confirmed the presence of oligomers. OC confirmed the presence of fibrils.

Dot blots can be seen in Figure 15. Antibody ab18018 confirmed the presence of amylin
for all time points. Oligomers were detected at the 4 and 6 hour time points. Fibrils were
detected at all time points. The 4 and 6 hour time points were noticeably darker for both
oligomers and fibrils.

The presence of positive peaks that showed consistent increases in both

peak size and peak area indicated the presence of aggregating species. While dot blots did detect
oligomers and fibrils, due to the detection of fibrils at all time points we were unable to use them
to conclusively monitor the formation of oligomers and determine the identity of the aggregated
amylin species within the capillary.
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In comparison with the pH, salt, and temperature studies the MV results were more
consistent. With the exception of positive peak area for the Salt study, the values obtained for
normalized elution time and peak area, both positive and negative, were similar to the other
studies. Though there was variance between individual runs, the MV results did result in
consistent increases for elution time and peak area. The electropherograms revealed an
interesting similarity between the salt and MV studies in comparison to the other three. The
negative peak for the salt and MV studies elutes after the positive peak while in the other three
studies it elutes before the positive peak. Both salt and MV studies also exhibited a system peak
between 1 and 2 minutes. The only similarity between the two studies was the high salt
concentration of 140 mM NaCl.

Improvements/ Causes for variance
Our results showed an overall consistent trend that these conditions do promote
aggregation, however some of the time courses were inconsistent with each other. It is our belief
that a variety of reasons led to this inconsistency. First is the preparation of amylin. Amylin was
purchased from Anaspec, and had a peptide content percentage of 83%. Therefore 17% of the
sample was not amylin. We do not know the identity of this 17%. It is possible that it may have
contained some sort of contaminant. In addition, our preparation method involved the use of
HFIP to dissolve the sample and aliquot it out. There are other preparation methods available
that might remove this 17% as well as reduce amylin to its monomeric form such as size
exclusion chromatography. Size exclusion chromatography separates molecules based on their
size and molecular weight 38. This would allow us to better purify the amylin sample so that only
the monomeric form of amylin remains.
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Our method of detection/ separation using capillary electrophoresis involved the use of a
bare siliconized capillary. The inside of this capillary is negatively charged 39. Amylin is
positively charged which results in “sticking” of the protein on the interior wall of the capillary
40

. Sticking could be the cause of variance between our individual CE runs. To alleviate this

sticking a coating polymer can be used to neutralize the interior capillary surface. Unfortunately,
preliminary results with a coating polymer, PEO, had inconsistent current. Perhaps this could be
improved in the future by examining other coatings.
CE can also be performed with a polymer matrix to enhance the resolution of different
species. We performed preliminary tests to determine if amylin could be studied using a
polymer matrix. Both the absorbance and currents were inconsistent. We therefore chose to
forgo using a polymer matrix. It might be possible to get more consistent absorbance and current
if we were to utilize a different polymer for both coating and separation such as PHEA or PVA
41

.
Also of concern is the specificity of our primary ab18018 antibody. A control study was

conducted to confirm its specificity. We blotted 50 µM amylin along with 50 µM BSA and our
sample Tris buffer. We expected to only observe the amylin dot; however the ab18018 detected
both the amylin and the BSA which can be seen in Figure 16. The BSA blot was not as strong as
the amylin’s, but its presence indicates the potential for a false positive. This makes it difficult
to use to confirm the presence of amylin within our samples. For future work there will need to
be a new, more specific antibody selected.
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Figure 16: Control dot blot study for the specificity of AB18018 antibody. 50 µM Amylin, 50
µM BSA, and 43 mM Tris sample buffer were blotted onto a nitrocellulose membrane. Positive
blots have been circled.

Previous work has revealed amylin aggregation can be concentration dependent. While
our 50 µM amylin concentration was acceptable, higher concentrations have been shown to
result in a faster aggregation rate 24. It would be prudent to observe variations in concentrations
under our solutions conditions for future work.
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Appendix
Mixing Table for Amylin at 50 µM
Samples
5mM NaOH (ul) 40mM Tris –HCl (ul)
Control
13.66
259.32
pH 1
13.66
259.32
Salt 1
13.66
250.93
Agitation 1 13.66
259.32
Agitation 2 13.66
259.32
Temp1
13.66
259.32
Body 1
13.66
250.93

5mM NaCL (ul)
.295
.295
0
.295
.295
.295
0

140mM NaCl (ul)
0
0
8.68
0
0
0
8.68

Tris Buffer Preparation
Grams/liter Grams/liter
pH pH
pH
for 0.05 M for 0.05 M
at
at
at
5°C 25°C 37°C Tris HCl
Tris Base
7.55
7
6.7
7.28
0.47
7.66
7.1
6.8
7.13
0.57
7.76
7.2 6.91
7.02
0.67
7.89
7.3 7.02
6.85
0.8
7.97
7.4 7.12
6.61
0.97
8.07
7.5 7.22
6.35
1.18
8.18
7.6
7.3
6.06
1.39
8.26
7.7
7.4
5.72
1.66
8.37
7.8 7.52
5.32
1.97
8.48
7.9 7.62
4.88
2.3
8.58
8 7.71
4.44
2.65
8.68
8.1
7.8
4.02
2.97
8.78
8.2 7.91
3.54
3.34
8.88
8.3 8.01
3.07
3.7
8.98
8.4
8.1
2.64
4.03
9.09
8.5 8.22
2.21
4.36
9.18
8.6 8.31
1.83
4.65
9.28
8.7 8.42
1.5
4.9
9.36
8.8 8.51
1.23
5.13
9.47
8.9 8.62
0.96
5.32
9.56
9
8.7
0.76
5.47
9.67
9.1 8.79
0.69
5.53
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Buffer was made to 43.56 mM concentration so that upon dilution with amylin, NaOH, and NaCl
buffer concentration would be 40 mM.
Procedures:
40 mM pH 8
Made at 25oC for use at 25oC
At 25oC pH should be 8.0
1.
2.
3.
4.
5.

Weigh out 0.7736 mg Tris – HCl crystals (0.0049 moles)
Weigh out 0.4617 mg Tris Base crystals (.0038 moles)
Add to .2 L deionized H2O
Titrate with Tris Base or Acid to reach appropriate pH
Filter into container

100 mM pH 8
Made at 25oC for use at 25oC
At 25oC pH should be 8.0
1.
2.
3.
4.
5.

Weigh out 1.776 g Tris – HCl crystals (0.0113 moles)
Weigh out 1.06 g Tris Base crystals (0.00875 moles)
Add to 0.2 L deionized H2O
Titrate with Tris Base or Acid to reach appropriate pH
Filter into container

40 mM pH 8
Made at 25oC for use at 37oC
At 25oC pH should be 8.3
1.
2.
3.
4.
5.

Weigh out 0.535 g of Tris – HCl crystals (0.00339 moles)
Weigh out 0.645 g of Tris Base crystals (0.00532 moles)
Add to 0.2 L of deionized H2O
Titrate with Tris Base or Acid to reach appropriate pH
Filter into container
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40 mM pH 7
Made at 25oC for use at 25oC
At 25oC pH should be 7.0
1.
2.
3.
4.
5.

Weigh out 0.3171 g Tris – HCl (0.0021 moles)
Weigh out 0.0020 g Tris Base (1.69 E -5 moles)
Add to 0.05 L deionized H2O
Titrate with Tris acid to reach appropriate pH
Filter into container

100 mM pH 7
Made at 25oC for use at 25oC
At 25oC pH should be 7.0
1.
2.
3.
4.
5.

Weigh out 0.728 g Tris – HCl (0.00462 moles)
Weigh out 0.0047 g Tris Base (3.879E -5 moles)
Add to 0.05 L deionized H2O
Titrate with tris acid to reach appropriate pH
Filter into container
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HFIP Preparation
Monomerization by HFIP and storage of Amylin

Stock Solutions:
A. Assay Buffer:
HFIP (1,1,1,3,3,3-hexafluoro-2-propanol)
B. Amylin: 1mg/vial

Anaspec

Procedure:
1. Amylin is stored as a solid at -80C. Remove and place on ice when ready to prepare stock
peptide films.
2. Place 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) on ice in the hood and allow to cool. HFIP is
highly corrosive and very volatile. Add enough HFIP to Amylin such that the final peptide
concentration is 1mM (e.g. 256 ul cold HFIP to 1 mg Amylin). Rinse vial thoroughly.
3. Incubate at room temperature for 60 min, keeping vial closed. Solution should be clear and
colorless. Any traces of yellow color or cloudy suspension indicate poor peptide quality and
should not be used.
4. Place peptide—HFIP solution back on ice for 5–10 min.
5. Separate the HFIP into vials with 0.0625 mg/vial. That means each vial has 16 µL stock.
6. Aliquot solution into non-siliconized microcentrifuge tubes. Do not close tubes.
7. Allow HFIP to evaporate overnight in the hood at room temperature.
8. All traces of HFIP must be removed. The resulting peptide should be a thin clear film at the
bottom of the tubes. The peptide should not be white or chunky.
9. Store dried peptide films over desiccant at -80C. These stocks should be stable for several
months.
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Sample Preparation
Agitation 1
1. Remove vial with .0625 mg amylin from -80oC freezer
2. Prepare 50µM concentration using a proportion of 5 mM NaOH (add 13.66 µL of 5 mM
NaOH to vial)
3. Let dissolve for 10 minutes
4. Dilute into appropriate tris buffer by adding 259.3 µL of 43.56 mM Tris – HCl pH 8
(This will depend on which condition you are using.)
5. Add enough NaCl to solution such that the final NaCl concentration is 5 mM (add 0.295
µL, total volume should now be 273.27 µL)
6. Place on shaker at 0 rpm and 25oC.
7. Take time points according for the condition you are using.

Agitation 2
1. Remove vial with .0625 mg amylin from -80oC freezer
2. Prepare 50µM concentration using a proportion of 5 mM NaOH (add 13.66 µL of 5 mM
NaOH to vial)
3. Let dissolve for 10 minutes
4. Dilute into appropriate tris buffer by adding 259.3 µL of 43.56 mM Tris – HCl pH 8
(This will depend on which condition you are using.)
5. Add enough NaCl to solution such that the final NaCl concentration is 5 mM (add 0.295
µL, total volume should now be 273.27 µL)
6. Place on shaker at 800 rpm and 25oC.
7. Take time points according for the condition you are using.

Body 1
1. Remove vial with .0625 mg amylin from -80oC freezer
2. Prepare 50µM concentration using a proportion of 5 mM NaOH (add 13.66 µL of 5 mM
NaOH to vial)
3. Let dissolve for 10 minutes
4. Dilute into appropriate tris buffer by adding 250.9 µL of 43.56 mM Tris – HCl pH 8 for
use at 37oC (This will depend on which condition you are using.)
5. Add enough NaCl to solution such that the final NaCl concentration is 5 mM (add 8.679
µL, total volume should now be 273.27 µL)
6. Place on shaker at 0 rpm and 37oC.
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7. Take time points according for the condition you are using.
Control 1
1. Remove vial with .0625 mg amylin from -80oC freezer
2. Prepare 50µM concentration using a proportion of 5 mM NaOH (add 13.66 µL of 5 mM
NaOH to vial)
3. Let dissolve for 10 minutes
4. Dilute into appropriate tris buffer by adding 259.3 µL of 43.56 mM Tris – HCl pH 8
(This will depend on which condition you are using.)
5. Add enough NaCl to solution such that the final NaCl concentration is 5 mM (add 0.295
µL, total volume should now be 273.27 µL)
6. Place on shaker at 400 rpm and 25oC.
7. Take time points according for the condition you are using.
pH 1
1. Remove vial with .0625 mg amylin from -80oC freezer
2. Prepare 50µM concentration using a proportion of 5 mM NaOH (add 13.66 µL of 5 mM
NaOH to vial)
3. Let dissolve for 10 minutes
4. Dilute into appropriate tris buffer by adding 259.3 µL of 43.56 mM Tris – HCl, pH 7.0
5. Add enough NaCl to solution such that the final NaCl concentration is 5 mM (add 0.295
µL, total volume should now be 273.27 µL)
6. Place on shaker at 400 rpm and 25oC.
7. Take time points according for the condition you are using.
Salt 1
1. Remove vial with .0625 mg amylin from -80oC freezer
2. Prepare 50µM concentration using a proportion of 5 mM NaOH (add 13.66 µL of 5 mM
NaOH to vial)
3. Let dissolve for 10 minutes
4. Dilute into appropriate tris buffer by adding 250.3 µL of 43.56 mM Tris – HCl pH 8
(This will depend on which condition you are using.)
5. Add enough NaCl to solution such that the final NaCl concentration is 5 mM (add 8.679
µL, total volume should now be 273.27 µL)
6. Place on shaker at 400 rpm and 25oC.
7. Take time points according for the condition you are using.
Temp 1
1. Remove vial with .0625 mg amylin from -80oC freezer
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2. Prepare 50µM concentration using a proportion of 5 mM NaOH (add 13.66 µL of 5 mM
NaOH to vial)
3. Let dissolve for 10 minutes
4. Dilute into appropriate tris buffer by adding 259.3 µL of 43.56 mM Tris – HCl pH 8 for
use at 37oC (This will depend on which condition you are using.)
5. Add enough NaCl to solution such that the final NaCl concentration is 5 mM (add 0.295
µL, total volume should now be 273.27 µL)
6. Place on shaker at 400 rpm and 37oC.
7. Take time points according for the condition you are using.

Dot Blot Protocol
Procedure
AB 18018 primary antibody
1.
2.
3.
4.

Use only tweezers when handling nitrocellulose membranes
Cut nitrocellulose membranes into half inch wide strips
Spot 2 µL of sample onto each membrane for each time point
After all spots have been applied to membrane, allow last applied spot to dry, approx 10
min to 1 hour
5. Block membranes in 5% nonfat milk/TBS-T solution (15 ml) at RT for 1 hour with gentle
shaking
6. Wash membranes 3 times in 1X TBS – T
7. Cover each membrane with the following amounts of primary antibody AB18018 5 mL
0.1% BSA/TBS-T + 1.0 µL 6E10 primary antibody (1:5000 dilution)
8. Incubate overnight at 4 degrees C
9. Decant antibody solution and rinse 3 times in 1X TBS – T
10. Cover membrane with 5 ml 0.1% BSA/TBST + 10.0 ul secondary antibody (goat-antimouse conj. Alkaline phosphatase) at RT for 1 hour with gentle shaking
11. Decant antibody solution and rinse 3 times with 1X TBS – T
12. Apply 5 mL of visualization solution and shake gently
13. Decant solution and use water to stop reaction when dots develop
14. Dry in a kim wipe
A11 primary antibody
1. Use only tweezers when handling nitrocellulose membranes
2. Cut nitrocellulose membranes into half inch wide strips
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3. Spot 2 µL of sample onto each membrane for each time point
4. After all spots have been applied to membrane, allow last applied spot to dry, approx 10
min to 1 hour
5. Block membranes in 5% nonfat milk/TBS-T solution (15 ml) at RT for 1 hour with gentle
shaking
6. Wash membranes 3 times in 1X TBS – T
7. Cover each membrane with the following amounts of primary antibody AB18018 5 mL
0.1% BSA/TBS-T + 1.0 µL 6E10 primary antibody (1:5000 dilution)
8. Incubate overnight at 4 degrees C
9. Decant antibody solution and rinse 3 times in 1X TBS – T
10. Cover membrane with 5 ml 0.1% BSA/TBST + 10.0 ul secondary antibody (goat-antimouse conj. Alkaline phosphatase) at RT for 1 hour with gentle shaking
11. Decant antibody solution and rinse 3 times with 1X TBS – T
12. Apply 5 mL of visualization solution and shake gently
13. Decant solution and use water to stop reaction when dots develop
14. Dry in a kim wipe
OC primary antibody
1.
2.
3.
4.

Use only tweezers when handling nitrocellulose membranes
Cut nitrocellulose membranes into half inch wide strips
Spot 2 µL of sample onto each membrane for each time point
After all spots have been applied to membrane, allow last applied spot to dry, approx 10
min to 1 hour
5. Block membranes in 5% nonfat milk/TBS-T solution (15 ml) at RT for 1 hour with gentle
shaking
6. Wash membranes 3 times in 1X TBS – T
7. Cover each membrane with the following amounts of primary antibody AB18018 5 mL
0.1% BSA/TBS-T + 1.0 µL 6E10 primary antibody (1:5000 dilution)
8. Incubate overnight at 4 degrees C
9. Decant antibody solution and rinse 3 times in 1X TBS – T
10. Cover membrane with 5 ml 0.1% BSA/TBST + 10.0 ul secondary antibody (goat-antimouse conj. Alkaline phosphatase) at RT for 1 hour with gentle shaking
11. Decant antibody solution and rinse 3 times with 1X TBS – T
12. Apply 5 mL of visualization solution and shake gently
13. Decant solution and use water to stop reaction when dots develop
14. Dry in a kim wipe
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Th-T Protocol
Procedure: 1 mM Th-T Stock Solution
1. Weigh out 9.566 mg of Th-T powder
2. Mix with 30 mL deionized water
Procedure: Th-T solution 5mM NaCl and pH 8 for use at 25oC
Th-T should be in a concentration of 35.7 µM
1. Take a 15 mL tube and fill with 2407.87 µL Tris H-Cl pH 8 for use at 25oC
2. Add 2.27 µL 4400 mM NaCl
3. Add 89.29 µL 1 mM Th-T stock solution
Total volume should be 2500 µL
Procedure: Th-T solution 5mM NaCl and pH 8 for use at 37oC
Th-T should be in a concentration of 35.7 µM
1. Take a 15 mL tube and fill with 2407.87 µL Tris H-Cl pH 8 for use at 37oC
2. Add 2.27 µL 4400 mM NaCl
3. Add 89.29 µL 1 mM Th-T stock solution
Total volume should be 2500 µL
Procedure: Th-T solution 140mM NaCl and pH 8 for use at 37oC
Th-T should be in a concentration of 35.7 µM
1. Take a 15 mL tube and fill with 2331.16 µL Tris H-Cl pH 8 for use at 37oC
2. Add 79.55 µL 4400 mM NaCl
3. Add 89.29 µL 1 mM Th-T stock solution
Total volume should be 2500 µL
Procedure: Th-T solution 5mM NaCl and pH 7 for use at 25oC
Th-T should be in a concentration of 35.7 µM
1. Take a 15 mL tube and fill with 2407.87 µL Tris H-Cl pH 7 for use at 25oC
2. Add 2.27 µL 4400 mM NaCl
3. Add 89.29 µL 1 mM Th-T stock solution
Total volume should be 2500 µL
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CE Protocol
Capillary length
Cut capillary to appropriate length (31 cm) using jig
Separation Sequence
1.
2.
3.
4.

Rinse capillary with DI water for 10 minutes at 50 psi
Rinse capillary with 100 mM Tris for 2 minutes at 20 psi
Inject sample into capillary at 0.7 psi for 8 seconds
Separate at 7 kV for 60 minutes

*When programming the CE all steps should be done reverse so that separation occurs in the
short length of the capillary.
A new capillary should be used before each time course.
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